There are 2789 resources available
1279P - The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)
Presenter: Alexander Meisel
Session: ePoster Display
1280P - Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
Presenter: Qing Zhou
Session: ePoster Display
1311P - The role of inflammatory biomarkers in advanced non-small cell lung cancer patients treated with chemo-immunotherapy
Presenter: Emma Zattarin
Session: ePoster Display
1312P - Prognostic impact of KRAS status in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitor monotherapy
Presenter: Giacomo Pelizzari
Session: ePoster Display
1314P - Preliminary results of sequential combination of immunotherapy followed by chemotherapy in advanced non-small cell lung cancer
Presenter: Luc Heraudet
Session: ePoster Display
1315P - Impact of high fasting plasma glucose in the clinical outcome of patients with advanced NSCLC with PD-L1 ≥ 50% treated with frontline pembrolizumab
Presenter: Sandra Llop Serna
Session: ePoster Display
1317P - Renal toxicity in black patients with non-squamous non-small cell lung cancer treated with combination platinum-pemetrexed-pembrolizumab therapy
Presenter: Nino Balanchivadze
Session: ePoster Display